Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin I.

Musetti V, Masotti S, Prontera C, Storti S, Ndreu R, Zucchelli GC, Passino C, Emdin M, Clerico A.

Clin Chem Lab Med. 2018 Aug 28;56(9):e229-e231. doi: 10.1515/cclm-2018-0054. No abstract available.

PMID:
29679526
2.

A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods.

Clerico A, Belloni L, Carrozza C, Correale M, Dittadi R, Dotti C, Fortunato A, Vignati G, Zucchelli GC, Migliardi M; a document endorsed by the Italian Section of the European Ligand Assay Society (ELAS).

Clin Chem Lab Med. 2018 Feb 23;56(3):397-402. doi: 10.1515/cclm-2017-0881.

PMID:
29220884
3.

Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I.

Masotti S, Prontera C, Musetti V, Storti S, Ndreu R, Zucchelli GC, Passino C, Clerico A.

Clin Chem Lab Med. 2018 Feb 23;56(3):492-501. doi: 10.1515/cclm-2017-0387.

PMID:
28941350
4.

Pilot study on harmonization of cardiac troponin I immunoassays using patients and quality control plasma samples. On behalf of the Italian Section of the European Ligand Assay Society (ELAS) and of the Study Group on Cardiovascular Biomarkers of the Società Italiana di Biochimica Clinica (SIBioC).

Clerico A, Ripoli A, Masotti S, Prontera C, Storti S, Fortunato A, Buzzi P, Casagranda I, Franzini M, Ndreu R, Zucchelli GC, Zaninotto M, Plebani M.

Clin Chim Acta. 2016 May 1;456:42-48. doi: 10.1016/j.cca.2016.02.017. Epub 2016 Feb 26.

PMID:
26923393
5.

Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples.

Storti S, Masotti S, Prontera C, Franzini M, Buzzi P, Casagranda I, Ciofini E, Zucchelli GC, Ndreu R, Passino C, Clerico A.

Clin Chim Acta. 2015 Dec 7;451(Pt B):129-34. doi: 10.1016/j.cca.2015.09.016. Epub 2015 Sep 21.

PMID:
26391123
6.

State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC).

Fortunato A, Prontera C, Masotti S, Franzini M, Marchetti C, Giovannini S, Zucchelli GC, Emdin M, Passino C, Clerico A.

Clin Chim Acta. 2015 Apr 15;444:106-12. doi: 10.1016/j.cca.2015.01.028. Epub 2015 Feb 4.

PMID:
25661092
7.

Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform.

Prontera C, Masotti S, Franzini M, Emdin M, Passino C, Zucchelli GC, Clerico A.

Clin Chem Lab Med. 2015 Apr;53(5):e125-7. doi: 10.1515/cclm-2014-0873. No abstract available.

PMID:
25372724
8.

Harmonization protocols for thyroid stimulating hormone (TSH) immunoassays: different approaches based on the consensus mean value.

Clerico A, Ripoli A, Zucchelli GC, Plebani M.

Clin Chem Lab Med. 2015 Feb;53(3):377-82. doi: 10.1515/cclm-2014-0586.

PMID:
25241732
9.

State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study.

Clerico A, Zaninotto M, Prontera C, Giovannini S, Ndreu R, Franzini M, Zucchelli GC, Plebani M; Study Group on Cardiovascular Risk Biomarkers of the Italian Society of Clinical Biochemistry.

Clin Chim Acta. 2012 Dec 24;414:112-9. doi: 10.1016/j.cca.2012.07.017. Epub 2012 Aug 15.

PMID:
22910582
10.

Multicentre comparison of free thyroid hormones immunoassays: the Immunocheck study.

Giovannini S, Zucchelli GC, Iervasi G, Iervasi A, Chiesa MR, Mercuri A, Renieri A, Prontera C, Conte R, Clerico A.

Clin Chem Lab Med. 2011 Oct;49(10):1669-76. doi: 10.1515/CCLM.2011.647. Epub 2011 Jun 17.

PMID:
21679128
11.

Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study.

Prontera C, Zaninotto M, Giovannini S, Zucchelli GC, Pilo A, Sciacovelli L, Plebani M, Clerico A.

Clin Chem Lab Med. 2009;47(6):762-8. doi: 10.1515/CCLM.2009.153.

PMID:
19402791
12.

Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP.

Prontera C, Zucchelli GC, Vittorini S, Storti S, Emdin M, Clerico A.

Clin Chim Acta. 2009 Feb;400(1-2):70-3. doi: 10.1016/j.cca.2008.10.011. Epub 2008 Oct 26.

PMID:
18992732
13.

Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations.

Clerico A, Fortunato A, Ripoli A, Prontera C, Zucchelli GC, Emdin M.

Clin Chem Lab Med. 2008;46(6):804-8. doi: 10.1515/CCLM.2008.162.

PMID:
18601601
14.

Evaluation of analytical performance of the Siemens ADVIA TnI ultra immunoassay.

Prontera C, Fortunato A, Storti S, Mercuri A, Longombardo G, Zucchelli GC, Emdin M, Clerico A.

Clin Chem. 2007 Sep;53(9):1722-3. No abstract available.

15.

Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.

Iervasi A, Iervasi G, Ferdeghini M, Solimeo C, Bottoni A, Rossi L, Colato C, Zucchelli GC.

Clin Endocrinol (Oxf). 2007 Sep;67(3):434-41. Epub 2007 Jun 6.

PMID:
17555505
16.

Gender-related differences in oxidative stress levels among elderly patients with coronary artery disease.

Vassalle C, Maffei S, Boni C, Zucchelli GC.

Fertil Steril. 2008 Mar;89(3):608-13. Epub 2007 Jun 4.

PMID:
17548077
17.

Automation and validation of a fast method for the assessment of in vivo oxidative stress levels.

Vassalle C, Boni C, Di Cecco P, Ndreu R, Zucchelli GC.

Clin Chem Lab Med. 2006;44(11):1372-5.

PMID:
17087652
18.

Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.

Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.

Climacteric. 2006 Dec;9(6):452-8.

PMID:
17085378
19.

Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact.

Iervasi A, Iervasi G, Carpi A, Zucchelli GC.

Biomed Pharmacother. 2006 Sep;60(8):414-24. Epub 2006 Aug 17. Review.

PMID:
16959467
20.

Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system.

Storti S, Prontera C, Parri MS, Iervasi A, Vittorini S, Emdin M, Zucchelli GC, Longombardo G, Migliorini P, Clerico A.

Clin Chem Lab Med. 2006;44(8):1022-9.

PMID:
16879072
21.

Role of superoxide dismutase in vascular inflammation and in coronary artery disease.

Lubrano V, Di Cecco P, Zucchelli GC.

Clin Exp Med. 2006 Jun;6(2):84-8.

PMID:
16820996
22.

Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.

Maffei S, Mercuri A, Zucchelli GC, Vassalle C.

Int J Cardiol. 2006 Feb 15;107(2):194-9.

PMID:
16412796
23.

Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide.

Prontera C, Storti S, Emdin M, Passino C, Zyw L, Zucchelli GC, Clerico A.

Clin Chem. 2005 Jul;51(7):1274-6. No abstract available.

24.

Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease.

Lubrano V, Cocci F, Battaglia D, Papa A, Marraccini P, Zucchelli GC.

J Clin Lab Anal. 2005;19(3):110-4.

PMID:
15900566
25.

Clinical relevance of biological variation of B-type natriuretic peptide.

Clerico A, Zucchelli GC, Pilo A, Emdin M.

Clin Chem. 2005 May;51(5):925-6. No abstract available.

26.

Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma B-type natriuretic peptide (BNP) and N-terminal proBNP.

Clerico A, Prontera C, Emdin M, Passino C, Storti S, Poletti R, Zyw L, Zucchelli GC.

Clin Chem. 2005 Feb;51(2):445-7. No abstract available. Erratum in: Clin Chem. 2005 Apr;51(4):798.

27.

About the relationship between infection and atherosclerosis: the importance of adequate serological markers.

Vassalle C, Zucchelli GC, Giustini C.

Atherosclerosis. 2004 Nov;177(1):211-2; author reply 213-4. No abstract available.

PMID:
15488886
28.

Oxidative stress and its association with coronary artery disease and different atherogenic risk factors.

Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC.

J Intern Med. 2004 Oct;256(4):308-15.

29.

Diagnostic performance of a new highly sensitive thyroglobulin immunoassay.

Iervasi A, Iervasi G, Bottoni A, Boni G, Annicchiarico C, Di Cecco P, Zucchelli GC.

J Endocrinol. 2004 Aug;182(2):287-94.

PMID:
15283689
30.

Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure.

Emdin M, Passino C, Prontera C, Iervasi A, Ripoli A, Masini S, Zucchelli GC, Clerico A.

Clin Chem Lab Med. 2004;42(6):627-36.

PMID:
15259379
31.

Evidence for association between hepatitis C virus seropositivity and coronary artery disease.

Vassalle C, Masini S, Bianchi F, Zucchelli GC.

Heart. 2004 May;90(5):565-6. No abstract available.

32.

In vivo total antioxidant capacity: comparison of two different analytical methods.

Vassalle C, Masini S, Carpeggiani C, L'Abbate A, Boni C, Zucchelli GC.

Clin Chem Lab Med. 2004 Jan;42(1):84-9.

PMID:
15061386
34.
35.

Supraregional interlaboratory quality-control survey for an immunoradiometric renin assay.

Piffanelli A, Morganti A, Mantero F, Cianetti A, Zucchelli GC, Giovannini G, Pelizzola D.

Clin Chem. 2001 Dec;47(12):2148-50. No abstract available.

36.

Analytical performance of free PSA immunoassays: results from an interlaboratory survey.

Zucchelli GC, Pilo A, Chiesa MR, Cohen R, Bizollon CA.

Clin Chem. 1997 Dec;43(12):2426-8. No abstract available.

37.

Progress report of an external quality assessment scheme for cyclosporine assay.

Zucchelli GC, Pilo A, Chiesa MR, Scarlattini M, Bizollon CA.

Ther Drug Monit. 1996 Jun;18(3):273-9.

PMID:
8738767
38.

Performance of immunoassays for ca 19-9, ca 15-3 and ca 125 tumour markers evaluated from an international quality assessment survey.

Pilo A, Zucchelli GC, Cohen R, Chiesa MR, Bizollon CA.

Eur J Clin Chem Clin Biochem. 1996 Feb;34(2):145-50.

PMID:
8833648
39.

Comparison of immunoassays for tumor markers CA 19-9, CA 15-3 and CA 125: data from an international quality assessment scheme.

Pilo A, Zucchelli GC, Cohen R, Bizollon CA, Cappelli G, Cianetti A, Gion M, Piffanelli A, Bombardieri E.

Tumori. 1995 Mar-Apr;81(2):117-24.

PMID:
7539965
40.
41.

'Oncocheck': an international external quality assessment scheme for immunoassays of tumor markers.

Cohen R, Zucchelli GC, Fraysse M, Pilo A, Rigault MY, Grillet S, Bizollon CA.

Nucl Med Biol. 1994 Apr;21(3):483-93.

PMID:
9234309
42.

Analytical performance of CA 19.9, CA 125 and CA 15.3 assays as observed through an external quality assessment program.

Zucchelli GC, Pilo A, Chiesa MR, Masini S, Clerico A.

Int J Biol Markers. 1994;9(1):43-7.

PMID:
8051434
43.

Critical evaluation of endothelins assay.

Clerico A, Del Chicca MG, Zucchelli GC, Biver P, Mariani G, Bertelli A, Bertelli AA.

Int J Tissue React. 1994;16(2):79-87.

PMID:
7960504
44.

Performance of a fully automated fluorometric enzyme immunoassay for serum myoglobin measurement.

Clerico A, Del Chicca MG, Zucchelli GC, Salutini L, Mercuri A, Scarlattini M.

J Nucl Biol Med. 1993 Jun;37(2):83-7.

PMID:
8373838
45.

Growing use of nonisotopic CA 19-9 immunoassays increases between-laboratory variability.

Zucchelli GC, Pilo A, Chiesa MR, Cohen R, Bizollon CA.

Clin Chem. 1993 May;39(5):909-11. No abstract available.

46.

Presence of endogenous digitalis-like factors in milk.

Biver P, Clerico A, Del Chicca MG, Zucchelli GC, Cipolloni C.

Clin Chem. 1993 Apr;39(4):695. No abstract available.

PMID:
8472371
47.

Immunoradiometric assay of serum myosin as a marker of myocardial cell damage: methodological and clinical evaluation.

Clerico A, Emdin M, Del Chicca MG, Carpeggiani C, Zucchelli GC, Boni C, Di Pasquale G, Pinelli G.

J Nucl Biol Med. 1993 Mar;37(1):33-7.

PMID:
8329475
48.

Immunoassay of CEA, CA 19-9, CA 125, and CA 15-3 on the automated systems ES 300 and ES 600: methodological evaluation from a multicentre collaborative study.

Zucchelli GC, Pilo A, Jaworek D, Masini S, Chiesa MR.

Eur J Clin Chem Clin Biochem. 1992 Dec;30(12):875-9.

PMID:
1489864
50.

External quality assurance of the carcinoembryonic antigen (CEA) assay: main findings in six years' experience.

Zucchelli GC, Ferdeghini M, Pilo A, Clerico A, Masini S, Prontera C.

Int J Biol Markers. 1992 Jul-Sep;7(3):154-9.

PMID:
1431338

Supplemental Content

Loading ...
Support Center